The Tobacco Dependence Program (TDP) is dedicated to reducing the harm to health caused by tobacco use.
The TDP particularly aims to provide expertise on quitting smoking for those who need it most.
We do this through education, treatment, research and advocacy.
 
Research on Tobacco and Health Issues

In addition to providing education, treatment, and advocacy relating to tobacco, the Tobacco Dependence Program at Rutgers-School of Public Health aims to carry out and disseminate high
quality research on tobacco dependence and its treatment.

The Tobacco Dependence Program has collaborative links with the Center for Tobacco Surveillance and Evaluation Research (CTSER) within the School of Public Health as well as with numerous other healthcare agencies and research institutes throughout New Jersey. In addition to core funding from New Jersey Department of Health and Senior Services, Program faculty have obtained grants from national funding agencies such as the National Institute on Drug Abuse (NIDA), the Centers for Disease Control and Prevention (CDC), and the Association of Schools of Public Health (ASPH).

 

Many of the Tobacco Dependence Program faculty have a wealth of experience in
carrying out and publishing cutting-edge scientific research on tobacco dependence.
Some recent publications are given below.

2014

Steinberg MB, Zimmermann MH, Lewis MJ, Delnevo CD, Shukla P, Coups E, Foulds J; Comparing the Perceptions and Experiences of Inhaled Nicotine Devices:  E-cigarette vs. Nicotine Inhaler; 2014; J Gen Int Med; 29(11); 1444-50.

 

2013

Steinberg MB, Delnevo CD. Increasing the "Smoking Age": The Right Thing to Do.Ann Intern Med. 2013 Aug 26. doi: 10.7326/0003-4819-159-8-201310150-00695.

 

2011

Lin PN, Zimmermann MH, Bover MT, Schmelzer AC, Steinberg MB; Evaluation of graphic cigarette warning images on cravings to smoke; Journal of Smoking Cessation; 2011; 6(2): 85-88.

Sheffer C, Anders M, Brackman, S, Steinberg MB, Barone C. Tobacco intervention practices of primary care physicians treating lower socioeconomic status patients. American Journal of the Medical Sciences. (2011)

Delnevo CD, Gundersen DA, Hrywna M, Echeverria SE, Steinberg MB; Smoking-Cessation Prevalence Among U.S. Smokers of Menthol Versus Non-Menthol Cigarettes, Am J Prev Med 2011; 41(4):357-65.

Steinberg MB, Randall J, Greenhaus S, Schmelzer AC, Richardson DL, Carson JL; Tobacco Dependence Treatment for Hospitalized Smokers: A Randomized, Controlled, Pilot Trial Using Varenicline; Addictive Behaviors; 2011; 36:1127-32.

Steinberg MB, Zimmermann MH, Gundersen DA, Hart C, Delnevo CD; Physicians’ Perceptions Regarding Effectiveness of Tobacco Cessation Medications; Preventive Medicine (2011)

Williams JM, Steinberg MB, Steinberg ML, Gandhi KK, Ulpe R, Foulds J. Review of Varenicline for Tobacco Dependence: Panacea or Plight. Expert Opinion on Pharmacotherapy; 2011; 12(11):1799-812.

Delnevo CD, Steinberg MB, Hudson SV, Ulpe R, DiPaola RS. Epidemiology of Cigarette and Smokeless Tobacco Use among South Asian Immigrants in the Northeastern United States. J Oncol ; vol 2011; Article ID 252675, 8 pages, 2011.

Williams JM, Zimmermann MH, Steinberg ML, Gandhi KK, Delnevo C, Steinberg MB, Foulds J.
A Comprehensive Model for Mental Health Tobacco Recovery in New Jersey.
Admin Policy Ment Health; 2011; 38(5):368-83.

Steinberg MB, Bover, MT, Richardson DL, Schmelzer AC, Williams JM, Foulds J; Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies; Drug and Alcohol Dependence; 2011; 114:77-81.

2010

Williams JM, Zimmermann MH, Steinberg ML, Gandhi KK, Delnevo C, Steinberg MB, Foulds J.
A Comprehensive Model for Mental Health Tobacco Recovery in New Jersey. Adm Policy Ment Health. 2010

Steinberg MB, Bover, MT, Richardson DL, Schmelzer AC, Williams JM, Foulds J; Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies; Drug and Alcohol Dependence. 2010

Steinberg MB, Schmelzer AC, Lin PN, Garcia G; Smoking as a Chronic Disease; Current Cardiovascular Risk Reports; 2010; 4(6):413-20

Foulds J, Hughes J, Hyland A, Le Houezec J, McNeill A, Melvin C, Okuyemi K, Shiffman S, Wassum K, Williams L, Zeller M. Barriers to Use of FDA-Approved Smoking Cessation medications: Implications for Policy Action. Society for Research on Nicotine and Tobacco. March, 2009. (Paper submitted as evidence base for Citizens’ petition to FDA from ATTUD and SRNT).

Foulds J, Schmelzer AC, Steinberg MB. Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease. International Journal of Clinical Practice 2010 Jan; 64(2): 142-146.

Foulds J, Schmelzer AC, Steinberg MB. Treating tobacco dependence as a chronic illness and a key modifiable predictor of disease. International Journal of Clinical Practice 2010 Jan; 64(2): 142-146.

Foulds J. Use of nicotine replacement therapy to treat nicotine withdrawal syndrome and aid temporary abstinence. International Journal of Clinical Practice 2010 Feb; 64(3): 292-294.

Williams JM, Dwyer M, Verna M, Hanos Zimmermann M, Gandhi Kk, Galazyn M, Szkodny N, Molnar M, Kley R, Steinberg ML.  Evaluation Of The Choices Program Of Peer To Peer Tobacco Education And Advocacy.  Community Ment Health J, 2010;Published Online.

Williams JM, Steinberg ML, Hanos Zimmermann M, Gandhi Kk, Stipelman B, Budsock Pd, Ziedonis Dm.  Comparison Of Two Intensities Of Tobacco Dependence Counseling In Schizophrenia And Schizoaffective Disorder.  J Subst Abuse Treat, 2010;38, 384-393.

2009

Steinberg MB, Greenhaus S, Schmelzer AC, Bover MT, Foulds J, Hoover DR, Carson JL. Triple Combination Pharmacotherapy for Medically Ill Smokers. A Randomized Trial. Annals of Internal Medicine. 2009; 150(7): 447-454.

Aveyard P, Foulds J. The 2008 US Clinical Practice Guideline: the key recommendations and a commentary. www.treatobacco.net 2009 Ask the Experts. Accessed 01 March 2009.

Williams Jm, Steinberg, Ml, Hanos Zimmermann M, Gandhi Kk, Lucas G, Gonsalves D, Pearlstein I, Mccabe P, Galazyn M, & Salsberg E. Training Psychiatrists And Advanced Practice Nurses To Treat Tobacco Dependence. J Am Psychiatr Nurses Assoc, 2009;15(1), 50-58.

2008

Williams JM, Gandhi KK,Katsamanis Karavidas M, Steinberg ML, Lu S, Foulds J Open label study of craving in smokers with schizophrenia using nicotine nasal spray compared to nicotine patch. Journal of Dual Diagnosis 2008 4(4): 355-376

Williams JM Eliminating tobacco use in mental health facilities: Patients’ rights, public health, and policy issues. JAMA. 2008 Feb 6; 299(5):571-3.

Oredein T, Foulds J, Edwards NS , Dasika J . Motivating Adolescent Smokers to Quit through a School-Based Program: The Development of Youth Quit2Win. In: Lapointe M (Ed) Adolescent Smoking and Health Research. Pp171-190. Nova Science Publishers Inc. New York, 2008.

Foulds J, Furberg H. Is low-nicotine Marlboro snus really snus? Harm Reduction Journal. 2008; 5 (9)
5-9.

Bover MT, Foulds J, Steinberg MB, Richardson D, Marcella SW. Waking at night to smoke as a marker for tobacco dependence: patient characteristics and relationship to treatment outcome. International Journal of Clinical Practice. Feb 2008; 62(2):182-190.

Foulds J, Delnevo C, Zeidonis D, Steinberg M . Health Effects of Tobacco, Nicotine, and Exposure To Tobacco Smoke Pollution. Chapter for: Handbook of the Medical Consequences of Alcohol and Drug Abuse pp 423-459. Haworth Press, Binghamton, NY. 2008.

Steinberg MB, Schmelzer AC, Richardson D, Foulds J. Treating tobacco dependence as a chronic disease: a case illustration. Annals of Internal Medicine 2008 Apr 1;148(7):554-6.

2007

Williams J, Foulds J. Clinical case conference: successful tobacco dependence treatment in schizophrenia. Am J Psychiatry. 2007 February;164 (2):222-7.

Delnevo C, Lewis MJ, Foulds J. Taxing moist snuff by weight ain’t worth spit. Tobacco Control 2007 Feb;16(1):69.

Steinberg MB, Foulds J; Rimonabant for treating tobacco dependence; Vascular Health and Risk Management; 3(3):307-11; 2007.

Abatemarco DJ, Steinberg MB, Delnevo CD. Midwives' knowledge, perceptions, beliefs, and practice supports regarding tobacco dependence treatment.J Midwifery Womens Health. 2007 Sep-Oct; 52(5):451-7.

Foulds J, Kozlowski LT. Snus: What should the public health response be? Lancet 2007 June 16; 369:1976-78. Reprinted from the Lancet with permission from Elsevier, License Number: 1993660442297

Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis DM, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007 Aug;9(8):873-81.

Steinberg MB , Nanavati K, Delnevo CD, Abatemarco DJ. Predictors of self-reported discussion of cessation medications by physicians in New Jersey. Addict Behav. 2007 Dec;32(12):3045-53. Epub 2007 Aug 24.

Kozlowski LT, .Giovino GA, Edwards B, DiFranza J, Foulds J, Hurt R, Niaura R, Sachs DPL., Selby P, Dollar KM., Bowen D Cummings KM, Counts M, Fox B, Sweanor D, Ahern F. Advice on using over-the-counter nicotine replacement therapy- patch, gum, or lozenge- to quit smoking. Addictive Behaviors. 2007 Oct;32(10):2140-50.
Handout for patients: English, Spanish

Foulds J . Estrategias de reduccion del dano en el tabaquismo. In: Ruiz CJ & Fagerstrom K. (Eds). Tratado Tabaquismo. 2007

Foulds J. Risk profile of smokeless tobacco. Pp129-161 In: Harm Reduction In Nicotine Addiction: Helping People Who Can't Quit. A report by the Tobacco Advisory Group of the Royal College of Physicians. London: RCP, 2007.

Steinberg MB, Delnevo CD; Physician beliefs regarding effectiveness of tobacco dependence treatments: results from the NJ Health Care Provider Tobacco Survey. J Gen Intern Med. 2007 Oct; 22(10):1459-62. Epub 2007 Aug 29.

Williams JM. Using peer counselors to address tobacco use: the CHOICES program. Psychiatr Serv. 2007 Sep;58(9):1225.

Ziedonis, DM, Parks, J, Zimmermann, MH, & Mccabe, P. Program And System Level Interventions To Address Tobacco Amongst Individuals With Schizophrenia. J Dual Diagnosis 2007;3 (3-4), 151-175.

2006

Foulds J, Ramstrom L, Causal effects of smokeless tobacco on mortality in CPS-I and CPS-II? Cancer Causes and Control. 2006; 17(2):277-228. (let)

Ziedonis DM, Williams JM, Steinberg MB, Foulds J. Addressing tobacco addiction in office-based management of psychiatric disorders: practical considerations. Primary Psychiatry. 2006;13(2):51-63.

Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Research and Health 2006; 29(3): 228-235.

Foulds J, Williams JM, Order-Connors B, Edwards N, Dwyer M , Kline A, Ziedonis DM. Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment : the New Jersey experience. Alcohol Research and Health 2006; 29(3): 236-240.

Foulds F, Steinberg MB, Williams JM & Ziedonis DM. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug and Alcohol Review. 2006 Jan; 25(1):59-71.

Ramstrom LM, Foulds J. Role of snus (smokeless tobacco) in initiation and cessation of tobacco smoking in Sweden. Tobacco Control. 2006 Jun;15(3):210-14.

Foulds J. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline. International J Clin Pract. 2006 May; 60(5):571-576

Williams JM & Ziedonis DM. Snuffing out tobacco dependence: Ten reasons behavioral health providers need to be involved. Behavioral Healthcare. 2006; 26(5)27-31.

Williams JM, Cain BW, Fredericks T, O’Shaughnessy M. A tobacco treatment model for individuals with serious mental Illness. Psychiatric Services. 2006; 57(8):1210.

Foulds J, Williams JM, Gandhi KK . Racial differences in lung cancer. New England Journal of Medicine. 2006 May 4; 354 (18):1951-3. (let)

Delnevo C, Foulds J. Seasonal variations in stage of change among Quitline clients. Tobacco Control. 2006 Feb; 15(1): 70-1. (let)

Steinberg MB, Alvarez MS, Delnevo C, Kaufman I, Cantor JC. Disparity of physicians’ utilization of tobacco treatment services. Am J Health Behav. 2006;30(4)375-386.

Ziedonis DM Haberstroh S, Zimmerman MH, Miceli M, Foulds J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolescent Medicine Clinics. 2006 Jun;17(2): 381-410

Han ES, Foulds J, Steinberg MB, Gandhi KK, West B, Richardson D, Zelenetz S, Dasika J. Characteristics and smoking cessation outcomes of patients returning for repeat tobacco dependences treatment. International Journal of Clinical Practice. 2006 Sept; 60 (9):1068-74.

Steinberg MB, Akincigil A, Delnevo CD, Crystal S, Carson JL. Gender and age disparities for smoking-cessation treatment. Results of the 2001-2002 National Ambulatory Medical Care Survey. Am J Prev Med. 2006 May;30(5)405-12.

Ziedonis DM, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Research and Health 2006; 29(3): 228-235.

Ziedonis D, Haberstroh S, Zimmerman MH, Miceli M, Foulds J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolescent Medicine Clinics. 2006 Jun;17(2): 381-410

2005

Foulds J, Williams J. Tobacco use, cataracts and schizophrenia. American Journal of Psychiatry. 2005 May; 162 (5):1028 (let)

Williams J, Foulds J, Dwyer M, Order-Conners B, Springer M, Gadde P, Ziedonis DM. The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey. Journal of Substance Abuse Treatment. 2005; 28: 331-340

Williams JM, Ziedonis DM, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res. 2005 Nov 15; 79(2-3):323-35.

Steinberg ML, Williams JM, Steinberg HR, Krejci JA, Ziedonis DM. Applicability of the fagerstrom test for nicotine dependence in smokers with schizophrenia. Addict Behav. 2005 Jan;30(1):49-59.

Delnevo CN, Foulds J, Hrywna, M. Trading tobacco: are youths choosing cigars over cigarettes? Am J Pub Health. 2005 Dec; 95(12): 2123.

Boudreaux ED, Baumann BM, Friedman K, Ziedonis DM. Smoking stage of change and interest in an emergency department-based intervention. Acad Emerg Med. 2005 May;12(3):211-8.

Ziedonis DM, Williams JM, Steinberg ML, Smelson D, Krejci J, Sussner BD, Violette N, Foulds J. Addressing tobacco dependence among veterans with a psychiatric disorder: a neglected epidemic of major clinical and public health concern. In Isaacs SL (Ed): VA In The Vanguard: Building on Success In Smoking Cessation. Department of Veterans Affairs. pp 141-170. 2005.

Osinubi Omowunmi, Barbeau Elizabeth, Williams Jill M, Sorensen Glorian. Curbing the tobacco epidemic: the role of workplace tobacco control policies and programs in focus on smoking and health research. Nova Science Publishers, 2005. pp 1-75.

2004

Steinberg MB, Delnevo C, Foulds J, Pevzner E. Characteristics of smoking and cessation behaviors among high school students in New Jersey. Journal of Adolescent Health. 2004 Sep; 35 (3): 231-3.

Foulds J, Burke M, Steinberg M, Williams J, Ziedonis D. Advances in pharmacotherapy for tobacco dependence. Expert Opinion in Emerging Drugs 2004; 9:39-53. 2004 May; 9(1):39-53.

Williams J M, Ziedonis DM, Foulds J. A case series Nicotine nasal spray in the combination treatment of tobacco dependence in schizophrenia Psychiatric Services. 2004 Sep; 55 (9): 1064-6.

Delnevo C, Hrywna M, Steinberg MB, Foulds J. Cigar use before and after a cigarette excise tax increase in New Jersey. Addictive Behavior. 2004 Dec; 29(9):1799-807.

Steinberg ML., Williams JM, & Ziedonis DM. Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control. 2004 Jun; 13(2):206.

Williams JM, Ziedonis D. Addressing tobacco among individuals with mental illness or an addiction. Addictive Behavior. 2004 Aug; 29(6):1067-83.

Steinberg ML, Ziedonis DM, Krejci JA, Brandon TH. Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. J Consult Clin Psychol. 2004 Aug;72(4):723-28.

Sussman S, Patten CA, & Order-Connors, B. Tobacco use (Chapter 9). In: Addiction Counseling Review: Preparing for Comprehensive, Certification and Licensing Examinations. Robert Coombs (Ed.), York, PA: TechBooks. (2004)

Lewis MJ, Delnevo CD, Slade J. Tobacco industry direct mail marketing and participation by New Jersey adults. Am J Public Health. 2004 Feb;94(2):257-9.

Hrywna M, Adler RK, Delnevo CD, Slade JD. Content analysis and key informant interviews to examine community response to the purchase, possession, and/or use of tobacco by minors. J Community Health. 2004 Jun;29(3):209-16.

2003

Delnevo, C. D., Steinberg, M. B., Abatemarco, D. J., & Hausman, A . J Correlates of clinical preventive practices among internal medicine residents. Preventive Medicine. 2003; 36(6): 645-651.

Krejci J, Foulds J. Engaging patients in tobacco dependence treatment: assessment and motivational techniques. Psychiatric Annals. 2003 Jul; 33(7):436-444.

Stuyt E B, Order-Connors B, and Ziedonis DM . Addressing tobacco through program and system change in mental health and addiction treatment settings. Psychiatric Annals. 2003 Jul; 33(7):447-456.

Williams J M, and Hughes, J. R. Pharmacotherapy treatments for tobacco dependence among smokers with mental illness or addiction. Psychiatric Annals. 2003 Jul; 33(7):457-466.

May S, West R, Hajek P, Nilsson F, Foulds J, Meadow A. The use of videos to inform smokers about different nicotine replacement products. Patient Education and Counseling. 2003 Oct; 51(2):143-7.

Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden.. Tobacco Control. 2003 Dec;12 (4):349-59.

Ziedonis D M, Williams J M, and Smelson D. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. American Journal of the Medical Sciences. 2003 Oct; 326(4):223-230.

Ziedonis DM, and Williams JM. Management of smoking in people with psychiatric disorders. Current Opinion in Psychiatry. 2003;16(3), 305-315.

Ziedonis DM, and Williams JM. Addressing tobacco in mental health and addictions settings. Psychiatric Annals. 2003 Jul; 33(7):25-25.

Ziedonis D, Fiester S. Substance Abuse: Nicotine Dependence (Chapter 59). In Tasman A (ed), Psychiatry (2nd Edition). John Wiley and Sons, London, UK, 2003.

2002

Delnevo CD, Pevzner ES, Steinberg M B, Warren CW and Slade J. Cigar use in New Jersey among adolescents and adults. American Journal of Public Health. 2002; 92(6); 943-945.

Foulds J, Burke M, Richardson D and Kazimir E. Tobacco dependence treatment services in New Jersey New Jersey Medicine. 2002 Mar; 99(3):23-8. Review

Harakas P, Foulds J. Acute effects of glucose tablets on craving, withdrawal symptoms, and sustained attention in 12-h abstinent tobacco smokers. Psychopharmacology. 2002 May; 161(3):271-7.

Patkar AA, Lundy A, Leone FT, Weinstein SP, Gottheil E, Steinberg MB. Tobacco and alcohol use and medical symptoms among cocaine dependent patients. Substance Abuse. 2002; 23(2):105-114.

Steinberg MB, Delnevo CD, Hrywna M. Update in tobacco dependence treatment for New Jersey clinicians; New Jersey Medicine. 2002; 99(11)21-26.

Slade J, Connolly GN, Lymperis D. Eclipse: does it live up to its health claims? Tob Control. 2002 Jun;11 Suppl 2:ii64-70.

Hatsukami DK, Slade J, Benowitz NL, Giovino GA, Gritz ER, Leischow S, Warner
KE. Reducing tobacco harm: research challenges and issues. Nicotine Tob Res. 2002;4 Suppl 2:S89-101.

Shiffman S, Gitchell JG, Warner KE, Slade J, Henningfield JE, Pinney JM.
Tobacco harm reduction: conceptual structure and nomenclature for analysis and
research. Nicotine Tob Res. 2002;4 Suppl 2:S113-29.

Osinubi OY, Slade J. Tobacco in the workplace. Occup Med. 2002 Jan-Mar;17(1):137-58, vi. Review

2001

West R, Hajek P, Nilsson F, Foulds J, May S, Meadows A. Individual differences in preferences for and responses to four nicotine replacement products. Psychopharmacology.(Berl). 2001 Jan; 153(2):225-30.

Hajek P, West R, Lee A, Foulds J, Eiser JR, Main N. Randomized controlled trial of a midwife-delivered brief smoking cessation intervention in pregnancy. Addiction. 2001 Mar; 96(3):485-94.

Herbert M, Foulds J, Fife-Schaw C. No effect of cigarette smoking on attention or mood in non-deprived smokers. Addiction. 2001 Sep; 96(9):1349-56.

McNeill A, Foulds J, Bates C. Regulation of nicotine replacement therapies (NRT): a critique of current practice. Addiction. 2001 Dec; 96(12):1757-68.

Ziedonis DM, Krejci J, Atdjian S. Integrating Medications and Psychotherapy in the Treatment of Alcohol, Tobacco and Other Drug Addictions. In Kay J (Ed). Integrated Treatment of Psychiatric Disorders (Volume 20). Washington DC: American Psychiatric Press Inc. 2001, pp: 79-111.

Canova D, Myers ML, Smith DE, Slade J. Changing the future of tobacco marketing by understanding the mistakes of the past: lessons from "Lights". Tob Control. 2001;10 Suppl 1:i43-4.

2000

West R, Hajek P, Foulds J, Nilsson F, Burrows S, Meadows A. A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler. Psychopharmacology. 2000 Apr; 149(3):198-202.

George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ and Kosten TR. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry. 2000 Nov; 157(11):1835-1842.

Foulds J. The new NHS smoking campaign. BMJ 2000 Feb 12; 320(7232): 454.

Wilkenfeld J, Henningfield J, Slade J, Burns D, Pinney J. It's time for a change: cigarette smokers deserve meaningful information about their cigarettes. J Natl Cancer Inst. 2000 Jan 19;92(2):90-2.

Baker F, Ainsworth SR, Dye JT, Crammer C, Thun MJ, Hoffmann D, Repace JL,Henningfield JE, Slade J, Pinney J, Shanks T, Burns DM, Connolly GN, Shopland DR. Health risks associated with cigar smoking. JAMA. 2000 Aug 9;284(6):735-40.

Baker F, Thun M, Crammer C, Slade J, Henningfield JE, Burns D, Shanks T, Connolly GN, Dye JT. Health risks of cigar smoking. JAMA. 2000 Nov 8;284(18):2320-1.

Davis RM, Slade J, Ferry LH. Quality improvement and accountability in the treatment of tobacco dependence: the need for a national training and certification programme. Tob Control. 2000 Dec;9(4):355-8.

125 Paterson Street, Suite 2300 | New Brunswick, NJ 08903 | Phone 732 235-8222 | Fax 732 235-7144